These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 38508089)
1. B cell clonality in cancer. Bryushkova EA; Mushenkova NV; Turchaninova MA; Lukyanov DK; Chudakov DM; Serebrovskaya EO Semin Immunol; 2024 Mar; 72():101874. PubMed ID: 38508089 [TBL] [Abstract][Full Text] [Related]
2. Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8 Hladíková K; Koucký V; Bouček J; Laco J; Grega M; Hodek M; Zábrodský M; Vošmik M; Rozkošová K; Vošmiková H; Čelakovský P; Chrobok V; Ryška A; Špíšek R; Fialová A J Immunother Cancer; 2019 Oct; 7(1):261. PubMed ID: 31623665 [TBL] [Abstract][Full Text] [Related]
3. Checkpoint blockade immunotherapy enhances the frequency and effector function of murine tumor-infiltrating T cells but does not alter TCRβ diversity. Kuehm LM; Wolf K; Zahour J; DiPaolo RJ; Teague RM Cancer Immunol Immunother; 2019 Jul; 68(7):1095-1106. PubMed ID: 31104075 [TBL] [Abstract][Full Text] [Related]
4. Tumor-infiltrating lymphocytes in the immunotherapy era. Paijens ST; Vledder A; de Bruyn M; Nijman HW Cell Mol Immunol; 2021 Apr; 18(4):842-859. PubMed ID: 33139907 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Landscape of Tumor-Infiltrating T and B Cells in Human Cancer. Zheng M; Li YM; Liu ZY; Zhang X; Zhou Y; Jiang JL; Zhu P; Yang XM; Tang J; Chen ZN Front Immunol; 2021; 12():731329. PubMed ID: 35069521 [TBL] [Abstract][Full Text] [Related]
6. GITR ligation enhances functionality of tumor-infiltrating T cells in hepatocellular carcinoma. van Beek AA; Zhou G; Doukas M; Boor PPC; Noordam L; Mancham S; Campos Carrascosa L; van der Heide-Mulder M; Polak WG; Ijzermans JNM; Pan Q; Heirman C; Mahne A; Bucktrout SL; Bruno MJ; Sprengers D; Kwekkeboom J Int J Cancer; 2019 Aug; 145(4):1111-1124. PubMed ID: 30719701 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneous expansion of CD4+ tumor-infiltrating T-lymphocytes in clear cell renal cell carcinomas. Zhang Q; Jia Q; Deng T; Song B; Li L Biochem Biophys Res Commun; 2015 Feb; 458(1):70-6. PubMed ID: 25637538 [TBL] [Abstract][Full Text] [Related]
8. Anti-PD-1 increases the clonality and activity of tumor infiltrating antigen specific T cells induced by a potent immune therapy consisting of vaccine and metronomic cyclophosphamide. Weir GM; Hrytsenko O; Quinton T; Berinstein NL; Stanford MM; Mansour M J Immunother Cancer; 2016; 4():68. PubMed ID: 27777777 [TBL] [Abstract][Full Text] [Related]
9. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas. Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905 [TBL] [Abstract][Full Text] [Related]
10. Potential role of tumor-infiltrating T-, B-lymphocytes, tumor-associated macrophages and IgA-secreting plasma cells in long-term survival in the rectal adenocarcinoma patients. Zinovkin DA; Kose SY; Nadyrov EA; Achinovich SL; Los' DM; Gavrilenko TE; Gavrilenko DI; Yuzugulen J; Pranjol MZI Life Sci; 2021 Dec; 286():120052. PubMed ID: 34656554 [TBL] [Abstract][Full Text] [Related]
11. Emerging concepts regarding pro- and anti tumor properties of B cells in tumor immunity. Qin Y; Lu F; Lyu K; Chang AE; Li Q Front Immunol; 2022; 13():881427. PubMed ID: 35967441 [TBL] [Abstract][Full Text] [Related]
12. Clonality, Antigen Recognition, and Suppression of CD8 Hammerl D; Massink MPG; Smid M; van Deurzen CHM; Meijers-Heijboer HEJ; Waisfisz Q; Debets R; Martens JWM Clin Cancer Res; 2020 Jan; 26(2):505-517. PubMed ID: 31649042 [TBL] [Abstract][Full Text] [Related]
15. Reduction of immunosuppressive tumor microenvironment in cholangiocarcinoma by ex vivo targeting immune checkpoint molecules. Zhou G; Sprengers D; Mancham S; Erkens R; Boor PPC; van Beek AA; Doukas M; Noordam L; Campos Carrascosa L; de Ruiter V; van Leeuwen RWF; Polak WG; de Jonge J; Groot Koerkamp B; van Rosmalen B; van Gulik TM; Verheij J; IJzermans JNM; Bruno MJ; Kwekkeboom J J Hepatol; 2019 Oct; 71(4):753-762. PubMed ID: 31195061 [TBL] [Abstract][Full Text] [Related]
16. The Emerging Role of CD8 Corgnac S; Boutet M; Kfoury M; Naltet C; Mami-Chouaib F Front Immunol; 2018; 9():1904. PubMed ID: 30158938 [TBL] [Abstract][Full Text] [Related]
17. Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities. Laumont CM; Banville AC; Gilardi M; Hollern DP; Nelson BH Nat Rev Cancer; 2022 Jul; 22(7):414-430. PubMed ID: 35393541 [TBL] [Abstract][Full Text] [Related]
18. Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer. Jin R; Liu C; Zheng S; Wang X; Feng X; Li H; Sun N; He J Cancer Biol Med; 2020 Aug; 17(3):768-781. PubMed ID: 32944405 [No Abstract] [Full Text] [Related]
19. Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer. Harris RJ; Cheung A; Ng JCF; Laddach R; Chenoweth AM; Crescioli S; Fittall M; Dominguez-Rodriguez D; Roberts J; Levi D; Liu F; Alberts E; Quist J; Santaolalla A; Pinder SE; Gillett C; Hammar N; Irshad S; Van Hemelrijck M; Dunn-Walters DK; Fraternali F; Spicer JF; Lacy KE; Tsoka S; Grigoriadis A; Tutt ANJ; Karagiannis SN Cancer Res; 2021 Aug; 81(16):4290-4304. PubMed ID: 34224371 [TBL] [Abstract][Full Text] [Related]
20. Tumor-associated Tregs obstruct antitumor immunity by promoting T cell dysfunction and restricting clonal diversity in tumor-infiltrating CD8+ T cells. Noyes D; Bag A; Oseni S; Semidey-Hurtado J; Cen L; Sarnaik AA; Sondak VK; Adeegbe D J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35618289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]